Diagnostic accuracy of faecal immunochemical test for screening individuals with a family history of colorectal cancer

Alimentary Pharmacology and Therapeutics

Volumn 38, Issue 7, 2013, Pages 835-841

  Ng, S C ^a   Ching, J Y L ^a   Chan, V ^a   Wong, M C S ^a,b   Suen, B Y ^a   Hirai, H W ^a   Lam, T Y T ^a   W Lau, J Y ^a   Ng, S S M ^a   Wu, J C Y ^a   Chan, F K L ^a   Sung, J J Y ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b and Hong Kong Branch of CAS Center for Excellence in Animal Evolution and Genetics   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; COLONOSCOPY; COLORECTAL ADENOMA; COLORECTAL CANCER; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC KIT; DIAGNOSTIC TEST ACCURACY STUDY; FAMILY HISTORY; FECAL IMMUNOCHEMICAL TEST; FEMALE; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; PREDICTIVE VALUE; PRIORITY JOURNAL; SCREENING TEST; SENSITIVITY AND SPECIFICITY;

ADENOMA; AGED; COLONOSCOPY; COLORECTAL NEOPLASMS; CONFIDENCE INTERVALS; EARLY DETECTION OF CANCER; FECES; FEMALE; HUMANS; IMMUNOCHEMISTRY; MALE; MASS SCREENING; MIDDLE AGED;

EID: 84883472785     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/apt.12446     Document Type: Article

References (36)

1. Ng SC, Lau JY, Chan FK, et al,. Increased risk of advanced neoplasms among asymptomatic siblings of patients with colorectal cancer. Gastroenterology 2012; 144: 544-50.
2. Butterworth AS, Higgins JP, Pharoah P,. Relative and absolute risk of colorectal cancer for individuals with a family history: a meta-analysis. Eur J Cancer 2006; 42: 216-27.
3. Johns LE, Houlston RS,. A systematic review and meta-analysis of familial colorectal cancer risk. Am J Gastroenterol 2001; 96: 2992-3003.
4. McConnell JC,. Colonoscopy in patients with a primary family history of colon cancer. Dis Colon Rectum 1990; 33: 259.
5. Almendingen K, Hofstad B, Vatn MH,. Does a family history of cancer increase the risk of occurrence, growth, and recurrence of colorectal adenomas? Gut 2003; 52: 747-51.
6. Levin B, Lieberman DA, McFarland B, et al,. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. Gastroenterology 2008; 134: 1570-95.
7. Sung JJ, Lau JY, Young GP, et al,. Asia Pacific consensus recommendations for colorectal cancer screening. Gut 2008; 57: 1166-76.
8. Davila RE, Rajan E, Baron TH, et al,. ASGE guideline: colorectal cancer screening and surveillance. Gastrointest Endosc 2006; 63: 546-57.
9. Rex DK, Johnson DA, Anderson JC, Schoenfeld PS, Burke CA, Inadomi JM,. American College of Gastroenterology guidelines for colorectal cancer screening 2009 [corrected]. Am J Gastroenterol 2009; 104: 739-50.
10. Niv Y, Dickman R, Figer A, Abuksis G, Fraser G,. Case-control study of screening colonoscopy in relatives of patients with colorectal cancer. Am J Gastroenterol 2003; 98: 486-9.
11. Dove-Edwin I, Sasieni P, Adams J, Thomas HJ,. Prevention of colorectal cancer by colonoscopic surveillance in individuals with a family history of colorectal cancer: 16 year, prospective, follow-up study. BMJ 2005; 331: 1047.
12. Menges M, Fischinger J, Gartner B, et al,. Screening colonoscopy in 40- to 50-year-old first-degree relatives of patients with colorectal cancer is efficient: a controlled multicentre study. Int J Colorectal Dis 2006; 21: 301-7.
13. Guillem JG, Forde KA, Treat MR, Neugut AI, O'Toole KM, Diamond BE,. Colonoscopic screening for neoplasms in asymptomatic first-degree relatives of colon cancer patients. A controlled, prospective study. Dis Colon Rectum 1992; 35: 523-9.
14. Regula J, Rupinski M, Kraszewska E, et al,. Colonoscopy in colorectal-cancer screening for detection of advanced neoplasia. N Engl J Med 2006; 355: 1863-72.
15. Gutierrez-Ibarluzea I, Asua J, Latorre K,. Policies of screening for colorectal cancer in European countries. Int J Technol Assess Health Care 2008; 24: 270-6.
16. Wong MC, Tsoi KK, Ng SS, et al,. A comparison of the acceptance of immunochemical faecal occult blood test and colonoscopy in colorectal cancer screening: a prospective study among Chinese. Aliment Pharmacol Ther 2010; 32: 74-82.
17. Bazzoli F, Fossi S, Sottili S, et al,. The risk of adenomatous polyps in asymptomatic first-degree relatives of persons with colon cancer. Gastroenterology 1995; 109: 783-8.
18. Pariente A, Milan C, Lafon J, Faivre J,. Colonoscopic screening in first-degree relatives of patients with 'sporadic' colorectal cancer: a case-control study. The Association Nationale des Gastroenterologues des Hopitaux and Registre Bourguignon des Cancers Digestifs (INSERM CRI 9505). Gastroenterology 1998; 115: 7-12.
19. Atkin WS, Edwards R, Kralj-Hans I, et al,. Once-only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multicentre randomised controlled trial. Lancet 2010; 375: 1624-33.
20. Quintero E, Castells A, Bujanda L, et al,. Colonoscopy versus fecal immunochemical testing in colorectal-cancer screening. N Engl J Med 2012; 366: 697-706.
21. Hundt S, Haug U, Brenner H,. Comparative evaluation of immunochemical fecal occult blood tests for colorectal adenoma detection. Ann Intern Med 2009; 150: 162-9.
22. Brenner H, Haug U, Hundt S,. Inter-test agreement and quantitative cross-validation of immunochromatographical fecal occult blood tests. Int J Cancer 2010; 127: 1643-9.
23. Hardcastle JD, Chamberlain JO, Robinson MH, et al,. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet 1996; 348: 1472-7.
24. Kronborg O, Fenger C, Olsen J, Jorgensen OD, Sondergaard O,. Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet 1996; 348: 1467-71.
25. Mandel JS, Church TR, Bond JH, et al,. The effect of fecal occult-blood screening on the incidence of colorectal cancer. N Engl J Med 2000; 343: 1603-7.
26. Mandel JS, Bond JH, Church TR, et al,. Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study. N Engl J Med 1993; 328: 1365-71.
27. Lane JM, Chow E, Young GP, et al,. Interval fecal immunochemical testing in a colonoscopic surveillance program speeds detection of colorectal neoplasia. Gastroenterology 2010; 139: 1918-26.
28. Chiu HM, Lee YC, Tu CH, et al,. Association Between Early-Stage Colon Neoplasms and False-Negative Results from the Fecal Immunochemical Test. Clin Gastroenterol Hepatol 2013; 11: 832-8.
29. Hiraoka S, Kato J, Fujiki S, et al,. The presence of large serrated polyps increases risk for colorectal cancer. Gastroenterology 2010; 139: 1503-10, 1510.
30. Raginel T, Puvinel J, Ferrand O, et al,. A population-based comparison of immunochemical fecal occult blood tests for colorectal cancer screening. Gastroenterology 2013; 144: 918-25.
31. Cha JM, Lee JI, Joo KR, et al,. First-degree relatives of colorectal cancer patients are likely to show advanced colorectal neoplasia despite a negative fecal immunochemical test. Digestion 2012; 86: 283-7.
32. Wong MC, John GK, Hirai HW, et al,. Changes in the choice of colorectal cancer screening tests in primary care settings from 7,845 prospectively collected surveys. Cancer Causes Control 2012; 23: 1541-8.
33. Mitchell RJ, Brewster D, Campbell H, et al,. Accuracy of reporting of family history of colorectal cancer. Gut 2004; 53: 291-5.
34. Haug U, Hundt S, Brenner H,. Quantitative immunochemical fecal occult blood testing for colorectal adenoma detection: evaluation in the target population of screening and comparison with qualitative tests. Am J Gastroenterol 2010; 105: 682-90.
35. Castells A, Castellvi-Bel S, Balaguer F,. Concepts in familial colorectal cancer: where do we stand and what is the future? Gastroenterology 2009; 137: 404-9.
36. Castells A, Giardiello FM,. Familial colorectal cancer screening: so close, so far. Gastroenterology 2013; 144: 492-4.